Speech-Language Pathologists in Laporte, PA Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Mrs. Andrea Lynn Jensen, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 918 Main Street, Laporte, PA 18626 Phone: 570-946-7700 |
Miss Bethany Suzanne Genevro, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 918 Main Street, Laporte, PA 18626 Phone: 570-946-7700 |
News Archive
Researchers provide insight into how breast tissue stiffening promotes cancer development
A study provides new insight into how the stiffening of breast tissue plays a role in breast cancer development. By examining how mammary cells respond in a stiffness-changing hydrogel, bioengineers at the University of California San Diego discovered that several pathways work together to promote the transformation of breast cells into cancer cells.
Online health information affects people who cannot tolerate uncertainty
Turning to the Internet to find out what ails you is common, but for folks who have trouble handling uncertainty, "cyberchondria" - the online counterpart to hypochondria - worsens as they seek answers, a Baylor University researcher says.
Study highlights the increase in PSA screening for prostate cancer following revisions to USPSTF guidelines
In a large study led by Yale Cancer Center, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions to the recommendation by the U.S. Preventative Services Task Force (USPSTF) on screening.
First Edition: March 12, 2012
Today's health policy headlines focus significant attention on key issues, dynamics and even personalities that will be in play when the Supreme Court takes up the health law later this month.
Atlantic-Pacific Capital raises $701M through DRI Capital managed Drug Royalty II fund
Atlantic-Pacific Capital, a leading independent global placement agent, announced today the final closing of Drug Royalty II with $701 million of equity capital commitments. The Fund, managed by DRI Capital, had an initial target of $500 million and received tremendous support from a broad group of institutional investors across the U.S., Canada, Europe, Australia and Asia. Atlantic-Pacific Capital acted as the exclusive global placement agent and advisor.
› Verified 2 days ago